The evolution of bladder cancer treatment : Improvements in clinical management, enhanced clinical outcomes, and targeting newly identified molecular alterationsBAJORIN, Dean F.Seminars in oncology. 2007, Vol 34, Num 2, pp 73-74, issn 0093-7754, 2 p.Article

Advances in urologic oncology : Results progress from successful interdisciplinary researchBAJORIN, Dean F; MOTZER, Robert J; BOSL, George J et al.Journal of clinical oncology. 2006, Vol 24, Num 35, pp 5479-5481, issn 0732-183X, 3 p.Article

Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancerHERR, Harry W; DONAT, S. Machele; BAJORIN, Dean F et al.The Journal of urology. 2001, Vol 165, Num 3, pp 811-814, issn 0022-5347Article

Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumorsSHEINFELD, Joel; MOTZER, Robert J; RABBANI, Farhang et al.The Journal of urology. 2003, Vol 170, Num 4, pp 1159-1162, issn 0022-5347, 4 p., 1Article

Defining optimal therapy for muscle invasive bladder cancerHERR, Harry W; DOTAN, Zohar; DONAT, S. Machele et al.The Journal of urology. 2007, Vol 177, Num 2, pp 437-443, issn 0022-5347, 7 p.Article

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma : results of the Cancer and Leukaemia Group B 90102PHILIPS, George K; HALABI, Susan; SANFORD, Ben L et al.BJU international (Papier). 2008, Vol 101, Num 1, pp 20-25, issn 1464-4096, 6 p.Article

Overview of bladder Cancer trials in the Cancer and Leukemia Group BSMALL, Eric J; HALABI, Susan; DALBAGNI, Guido et al.Cancer. 2003, Vol 97, Num 8, pp 2090-2098, issn 0008-543X, 9 p., SUPConference Paper

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell TumorsCARVER, Brett S; SERIO, Angel M; BAJORIN, Dean et al.Journal of clinical oncology. 2007, Vol 25, Num 35, pp 5603-5608, issn 0732-183X, 6 p.Article

Etoposide and cisplatin chemotherapy for meta good-risk germ cell tumorsKONDAGUNTA, G. Varuni; BACIK, Jennifer; BAJORIN, Dean et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9290-9294, issn 0732-183X, 5 p.Article

Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testisPOHAR, Kamal S; RABBANI, Farhang; BOSL, George J et al.The Journal of urology. 2003, Vol 170, Num 4, pp 1155-1158, issn 0022-5347, 4 p., 1Article

Contemporary Lymph Node Counts During Primary Retroperitoneal Lymph Node DissectionTHOMPSON, R. Houston; CARVER, Brett S; BOSL, George J et al.Urology (Ridgewood, NJ). 2011, Vol 77, Num 2, pp 368-372, issn 0090-4295, 5 p.Article

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumorsKONDAGUNTA, G. Varuni; BACIK, Jennifer; DONADIO, Alessia et al.Journal of clinical oncology. 2005, Vol 23, Num 27, pp 6549-6555, issn 0732-183X, 7 p.Conference Paper

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladderDALBAGNI, Guido; RUSSO, Paul; BAJORIN, Dean et al.Journal of clinical oncology. 2002, Vol 20, Num 15, pp 3193-3198, issn 0732-183XArticle

Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public WorkshopJAROW, Jonathan P; LERNER, Seth P; O'DONNELL, Michael et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 2, pp 262-264, issn 0090-4295, 3 p.Article

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinomaMILOWSKY, Matthew I; DITTRICH, Christian; ROSENBERGG, Jonathan E et al.European journal of cancer (1990). 2014, Vol 50, Num 18, pp 3145-3152, issn 0959-8049, 8 p.Article

Activities and accomplishments of the cancer and leukemia Group B genitourinary committeeSMALL, Eric J; HALABI, Susan; KANTOFF, Phillip et al.Clinical cancer research. 2006, Vol 12, Num 11, issn 1078-0432, 3596s-3600s, 2Article

Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma Germ Cell tumorMAZUMDAR, Madhu; BACIK, Jennifer; TICKOO, Satish K et al.Journal of clinical oncology. 2003, Vol 21, Num 14, pp 2679-2688, issn 0732-183X, 10 p.Article

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancerHERR, Harry W; BOCHNER, Bernard H; DALBAGNI, Guido et al.The Journal of urology. 2002, Vol 167, Num 3, pp 1295-1298, issn 0022-5347Article

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal functionGALSKY, Matthew D; IASONOS, Alexia; MIRONOV, Svetlana et al.Cancer. 2007, Vol 109, Num 3, pp 549-555, issn 0008-543X, 7 p.Article

Cancer-testis antigens : Expression and correlation with survival in human urothelial carcinomaSHARMA, Padmanee; YU SHEN; SIJIN WEN et al.Clinical cancer research. 2006, Vol 12, Num 18, pp 5442-5447, issn 1078-0432, 6 p.Article

Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer : Impact of patient selection factors on outcomeSTEPHENSON, Andrew J; BOSL, George J; MOTZER, Robert J et al.Journal of clinical oncology. 2005, Vol 23, Num 12, pp 2781-2788, issn 0732-183X, 8 p.Article

Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. CommentarySTEPHENSON, Andrew J; BOSL, George J; BAJORIN, Dean F et al.The Journal of urology. 2005, Vol 174, Num 2, pp 557-560, issn 0022-5347, 4 p.Article

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder CancerAPOLO, Andrea B; RICHES, Jamie; SCHÖDER, Heiko et al.Journal of clinical oncology. 2010, Vol 28, Num 25, pp 3973-3978, issn 0732-183X, 6 p.Conference Paper

Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancerMILOWSKY, Matthew I; STADLER, Walter M; BAJORIN, Dean F et al.BJU international (Papier). 2008, Vol 102, Num 9, pp 1339-1344, issn 1464-4096, 6 p., bArticle

Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancerDODD, Paul M; MCCAFFREY, John A; MAZUMDAR, Madhu et al.Cancer investigation. 2000, Vol 18, Num 7, pp 626-634, issn 0735-7907Article